Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Retatrutide GLP-3 Vial All Retatrutide GLP-3 research Retatrutide (development code LY3437943) is a synthetic, once-weekly triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors that has been the subject of peer-reviewed phase 1 and phase 2 randomized controlled trials published in The New England Journal of Medicine, The Lancet, and Nature Medicine, including investigations of body weight, glycemic control, and hepatic steatosis in adult human participants
Lowest upfront cost: Patient assistance programs (if you qualify)
Help maintain a healthy metabolism over time
Check your skin every month for any changes in skin spots or any new skin growths
You may also want to meet with a registered dietician for diet and meal planning advice
US$ 24.95
US$ 24.20
US$ 26.28
US$ 26.50
